Methods: We conducted a retrospective chart review on all women presented with operable, stage II-III, breast cancer and received reduction mammoplasty to treat their cancer together with aesthetic reduction mammoplasty of the contralateral breast during the same time from the period October 2018 to June 2021 at Suez Canal University Hospital. Patient satisfaction was evaluated preoperatively and postoperatively using the breast Q Questionnaire. The primary outcome of this study was to figure out if oncoplastic breast surgeries can introduce valuable advantages such as reasonable operative time, very low complications rate, no delay in the delivery of adjuvant treatment, favorable cosmetic outcomes, and high patient satisfaction for a patient with breast cancer and large breast volume (gigantomastia type 1).

Results: A total of 36 patients were included. The mean age was 45.5 ± 8.5 years. 58.3% of the patients had breast cup size D. Stage III was the commonest 47.2%. We used wise pattern (inverted T) mammoplasty with inferior pedicle for tumors of upper quadrants (69.4%) and wise pattern (inverted T) mammoplasty with superomedial pedicle for tumors of the lower pole (27.7%) and inverted T with nipple-areola complex resection for central tumors (2.7%). The mean follow-up was 18.5, SD 8.1 months. About 8.3% of our patients developed surgical site infection, 13.8% had postoperative seroma and 8.3% had fat necrosis. Patient satisfaction regarding their breasts improved from 47.9 preoperatively to 67.3 postoperatively and this difference was statistically significant. During the follow-up, none of the cases experienced local recurrence